Option Care Health

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Option Care Health surpasses Q4 expectations, eyes growth opportunities

Option Care Health's Q4 performance reflects growth and resilience amidst inflation challenges. The company's financial strength, focus on efficiency, and strategic initiatives position it well for future expansion and value creation.

Option Care Health reports robust Q2 earnings amidst strategic growth focus

Option Care Health's Q2 2023 earnings call highlighted strong financial performance, with revenue growth and adjusted EBITDA exceeding expectations. The company's strategic initiatives focus on innovation, operational efficiency, and patient care excellence.
While facing challenges like reimbursement issues and cost pressures, Option Care Health remains optimistic about sustainable growth and shareholder value. Investments in capabilities and network expansion position the company for future opportunities.
Analysts' inquiries into revenue growth composition, cost challenges, and future outlooks were addressed with a focus on operational excellence and sustainable growth. Option Care Health's performance reflects a balance of financial strength and strategic vision.

Option Care Health excels in Q3 performance and eyes M&A for growth

Option Care Health's Q3 earnings call highlighted strong financial performance, successful collaboration, and strategic focus on M&A for shareholder value. Challenges include revenue pressure in Q4 and sustainability of procurement benefits for 2024 projections.

Option Care Health exceeds revenue expectations, eyes strategic growth

Option Care Health's strong financial performance in 2023 positions the company for continued growth.
Strategic initiatives, operational efficiencies, and engagement with payers highlight the company's resilience.
Navigating market dynamics, optimizing procurement benefits, and strategic growth remain key focus areas for 2024.

Option Care Health reports resilient Q1 performance and growth opportunities

Option Care Health's Q1 2024 performance showcased revenue growth, strong patient satisfaction, and resilience in maintaining financial strength.
Despite challenges from the cybersecurity incident and supply chain disruptions, the company remains focused on growth and operational improvements.
Opportunities lie in expanding services, portfolio diversification, and adapting to evolving patient needs for continued success in 2024.
With disciplined SG&A management and a commitment to patient care, Option Care Health is poised for growth and service expansion.

Option Care Health excels in Q2, boosts revenue outlook

Option Care Health's Q2 performance reflects resilience and strategic focus, driving revenue growth and operational efficiency.
Despite challenges, the company's strengths in financial management and capital deployment position it well for future opportunities.
With increased revenue expectations and a strong cash flow rebound, Option Care Health is poised for sustained growth and value creation.

Option Care Health reports resilient Q3 performance amid operational challenges

Option Care Health's Q3 2024 performance showcased growth and financial resilience amidst operational challenges.
The company's strategic focus on managing costs and pursuing growth initiatives positions it well to address upcoming gross margin pressures.
Despite facing headwinds, Option Care Health remains optimistic about its revenue outlook for the full year 2024 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BANNOCKBURN, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, will participate in the BofA Securities Health Care Conference, being held in Las Vegas, on Tuesday, May 14, 2024, including a fireside chat presentation at 2:20pm PT. The webcast will be available online at https://investors.optioncarehealth.com.

Option Care Health to Participate in the BofA Securities Health Care Conference

Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Option Care (OPCH) Upgraded to Buy: Here's What You Should Know

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Option Care Health (OPCH) Right Now?

Option Care Health, Inc. (NASDAQ:OPCH ) Q1 2024 Earnings Conference Call April 23, 2024 8:30 AM ET Company Participants Mike Shapiro - Chief Financial Officer John Rademacher - President & Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies David MacDonald - Truist Securities Lisa Gill - JPMorgan Matthew Larew - William Blair Pito Chickering - Deutsche Bank Michael Petusky - Barrington Research Joanna Gajuk - Bank of America Operator Good day and thank you for standing by. Welcome to the Option Care Health Q1 2024 Earnings Conference Call.

Option Care Health, Inc. (OPCH) Q1 2024 Earnings Call Transcript

Option Care (OPCH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.21 per share a year ago.

Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates

BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024.

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024

Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?

Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce First Quarter 2024 Financial Results and Host Conference Call

UnitedHealth Group

Homecare health services provider Option Care Health said on Thursday it has been affected by the cyberattack at UnitedHealth Group's Change Healthcare unit, but does not expect the hack to materially impact its finances.

Option Care Health says it is affected by UnitedHealth hack

Option Care Health, Inc. (OPCH) Q4 2023 Earnings Call Transcript

Option Care (OPCH) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.26 per share a year ago.

Option Care (OPCH) Tops Q4 Earnings and Revenue Estimates

BANNOCKBURN, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023.

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023

Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Option Care (OPCH) is on the Move, Here's Why the Trend Could be Sustainable

Addus HomeCare

DaVita

Encompass Health

The rising dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.

4 Stocks to Watch in a Resilient Outpatient Home Health Industry

Amazon

Stride

Modine Manufacturing

A company capable of generating earnings well above its interest expense can withstand financial hardship. LRN, MOD, AMZN and OPCH are in a strong enough position to meet financial obligations.

These 4 Stocks Boast Impressive Interest Coverage Ratio

Atmos Energy

Molina Healthcare

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOH, ATO, AMZN and OPCH are sound enough to meet financial obligations.

Pick These 4 Stocks With Amazing Interest Coverage Ratio

BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call

Option Care Health gives investors exposure to two healthcare megatrends: (i) the shift to healthcare delivery in the home; and (ii) the development of specialty pharmaceuticals. I believe OPCH holds a competitive moat, not only as the largest infusion provider in the US, but also due to its business model (predictable revenue and sticky client/customer base). I explain the street is highly conservative and project a ~150bps upside to FY24E EBITDA, and apply a ~15x multiple to that projection to arrive at my $38 2024 PT.

Option Care Health Is Delivering The Future Of Healthcare At Home

Celsius Holdings

Super Micro Computer

Analysts are hopeful that holiday shopping news will bode well for the economy after retail sales increased 0.3% in November. This moderate growth for the economy eased economist's outlooks on a looming recession.

The 3 Most Undervalued Russell 2000 Stocks to Buy for 2024

BANNOCKBURN, Ill., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that it anticipates completing the remaining $75 million of repurchases in the fourth quarter under the original authorization. In addition, the Company's Board of Directors approved an increase to its share repurchase program authorization from $250 million to $500 million. The program has no specified expiration date.

Option Care Health Announces Increased Share Repurchase Authorization

Pennant Group Inc

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, OPCH, ADUS and PNTG are well-poised to gain.

4 Stocks to Watch in an Evolving Outpatient Home Health Industry

Option Care Health easily beat analysts' models for revenue and earnings in the third quarter of 2023. The company also raised its full-year outlook -- but not enough to live up to Wall Street's already high expectations.

Why Option Care Health Stock Plummeted Today

Option Care Health, Inc. (NASDAQ:OPCH ) Q3 2023 Earnings Conference Call October 25, 2023 8:30 AM ET Company Participants Mike Shapiro - CFO John Rademacher - CEO Conference Call Participants David MacDonald - Truist Madeline Mollman - William Blair Lisa Gill - JPMorgan Joanna Gajuk - Bank of America Merrill Lynch Brian Tanquilut - Jefferies Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Michael Petusky - Barrington Research Operator Good day, and thank you for standing by. Welcome to the Option Care Health Third Quarter 2023 Earnings Conference Call.

Option Care Health, Inc. (OPCH) Q3 2023 Earnings Conference Call Transcript

Option Care (OPCH) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.21 per share a year ago.

News for Option Care Health Stock (OPCH)